Guardant Health, Inc.

US$150.87As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GHHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 20.64%
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) 1.66
PE TTM —
TSR TTM 62.19%
Mkt cap US$20.41B
ROIC (26.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$191
26.37%
(81.71%)
Hold 8|1|6|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.04
2.01
2.15
2.18
2.16%
2.38%
15.05%
14.79%
Revenue$B
1.246
1.290
1.267
1.303
(1.55%)
0.90%
0.94%
2.39%
Peers (US$20.41B)
Cap (US$)
PE
18.27B
36.22x
17.31B
68.65x
17.00B
34.65x
Capital
TTM
5Y
10Y
Leveragex
2.924
1.226
1.154
EBIT/Intx
1.093
0.164
0.161
Own earn%
10.08
(160.65)
(159.82)
Sh yield%
42.94
45.85
44.98
Owners
Insiders/Inst%
12.64
45.76
Short interest%
1.10
SBC / revenue%
0.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
9–18
$1 testx
0.0
Incr. ROIC%
11